series-b
Stage
About
Cebiotex develops nanofiber-based local therapies for oncology that deliver sustained release of anti-tumor agents directly at tumor resection sites to reduce cancer recurrence, currently in Phase 2 clinical stage.
Explore Cebiotex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.